Abstract
The epididymis exhibits a less restrictive physical blood–tissue barrier than the testis and, while numerous immunosuppressive factors have been identified in the latter, no mechanisms for epididymal immunotolerance have been identified to date. Therefore, data are currently insufficient to explain how the immune system tolerates the extremely large load of novel antigens expressed on sperm, which become present in the male body after puberty, i.e., long after central tolerance was established. This study tested the hypothesis that transforming growth factor beta (TGFβ) signaling in dendritic cells (DCs) is required for immunotolerance to sperm located in the epididymis, and that male mice lacking TGFβ signaling in DCs would develop severe epididymal inflammation. To test this, we employed adult Tgfbr2ΔDC males, which exhibit a significant reduction of Tgfbr2 expression and TGFβ signaling in DCs, as reported previously. Results show that Tgfbr2ΔDC males exhibit sperm-specific immune response and severe epididymal leukocytosis. This phenotype is consistent with epididymal loss of immunotolerance to sperm and suggests that TGFβ signaling in DCs is a factor required for a non-inflammatory steady state in the epididymis, and therefore for male tract homeostasis and function.
Introduction
The epididymis is already known for contributing directly to male reproductive function by promoting sperm maturation and serving as storage site for sperm (). The epididymal duct is lined by pseudo-stratified epithelia that form tight junctions and implement, among other important factors, a physical barrier. Importantly, sperm are immunogenic (, ) and become present in the body long after central (thymic) immunotolerance is established. The physical testicular barrier and testicular immunosuppressive factors (, ) are thought to maintain a non-inflammatory local steady state that is conducive to reproductive function. However, the epididymis exhibits a less restrictive physical barrier () and no active immunosuppressive mechanisms to prevent antisperm immunity have been identified in this organ (). Abundant mononuclear phagocytes (MPs) populate the epididymis and dendritic cells (DCs)—characterized by CD11c expression, typical DC morphology, and antigen presentation activity in vitro—constitute a substantial MP population present in the epididymis at steady state (). DCs link innate and adaptive components of the immune system, by either initiating immune responses or inducing immunotolerance (). Physiological roles for epididymal DCs have not yet been identified.
Transforming growth factor beta (TGFβ) isoforms 1, 2, and 3 are ligands that activate the same receptor complex (TGFβ receptors I and II) to induce signal transduction through canonical and non-canonical mediators (–). Although TGFβ isoforms are known to exert pleiotropic effects (, ), their immunological regulatory function is well established. TGFβ1 is an immunosuppressive cytokine as demonstrated in vivo with the global Tgfb1-null mouse (, ), and subsequently with a mouse carrying T cell-specific suppression of TGFβ signaling (). Importantly, the male reproductive tract synthesizes and secretes large amounts of TGFβ1: median concentrations of total and active TGFβ1 in seminal plasma are 85 and 1 ng/ml, respectively (). Although seminal plasma is largely a product of seminal vesicle secretion, gene and protein expression data suggest that the epididymis and vas deferens also express TGFβ isoforms and receptors (–).
This study tested the hypothesis that TGFβ signaling in DCs is required for immunotolerance to sperm, and that male mice lacking TGFβ signaling in DCs would develop severe epididymal inflammation. To test this, we employed adult Tgfbr2ΔDC males, which exhibit a significant reduction of Tgfbr2 expression and TGFβ signaling in DCs (). Our results show that Tgfbr2ΔDC males exhibit sperm-specific immune response and epididymal leukocytosis that can reach extremely severe stages. This phenotype is consistent with loss of immunotolerance to sperm and suggests that TGFβ signaling in DCs is a factor required for a non-inflammatory steady state in the epididymis, and therefore for male tract homeostasis and function.
Materials and Methods
Mice
Tgfbr2ΔDC mice () carrying a FoxP3-GFP knock-in allele () were generated and utilized under the guidelines of an animal protocol approved by the Kansas State University Institutional Animal Care and Use Committee (IACUC). Tgfbr2ΔDCRag2−/− mice were generated and utilized as approved in an University of Arizona IACUC approved animal protocol.
Histology
Male excurrent system and testicular tissues from Tgfbr2ΔDC, Tgfbr2ΔDCRag2−/−, and littermate control (Cre−) males aged 8–10 weeks were fixed in block by immersion in Bouin’s solution. Dissected epididymis and testis were blocked in paraffin and sectioned at 6 µm. Epididymal tissue sections were made parallel to the long axis of the organ to include both the proximal and distal epididymal segments. Testicular sections were made across the long axis. Sections were stained with hematoxylin and eosin and slides (one per organ) were analyzed and photographed with an Eclipse E600 microscope and DS-Vi1 camera head (Nikon).
Flow Cytometry
Epididymal, testicular, and renal tissues were processed for flow cytometry as recently reported in a peer-reviewed protocol optimized for non-lymphoid murine tissues (). Testicular tissue was completely dissociated after 45–60 min of incubation in the enzymatic step of this protocol, while epididymal tissue required 60–75 min. Splenocyte suspensions were obtained by mechanical dissociation of scissors minced spleen in Hank’s balanced salt solution containing HEPES (10 mM) and fetal bovine serum (5%). All cell suspensions were strained (70 µm), washed, and counted by the standard hemocytometer method prior to flow cytometry staining, which was conducted as reported previously (). The fixable cell viability dye eFluor 506 (eBiosciences) was employed as per the manufacturer’s recommendations. The flow cytometry antibodies employed were PE-Cy5 anti-mouse CD45 (clone 30-F11, eBiosciences), PE-Cy5 rat IgG2b, κ isotype antibody control (clone eB149/10H5, eBiosciences), APC anti-mouse CD25 (clone PC61, BioLegend), and APC rat IgG1, λ isotype antibody control (clone G0114F7, BioLegend). Following staining, cells were washed, fixed in 0.4% paraformaldehyde in PBS, and stored at 4°C protected from light until data acquisition (24–48 h), as reported previously (). Compensation samples were UltraComp compensation beads (eBiosciences) stained with antibodies or splenocytes stained with the viability dye as per the manufacturer’s recommendations or unstained splenocytes, which contained the green fluorescent protein (GFP) signal in regulatory T cells (Tregs). Data were acquired in a LSR Fortessa X20 (BD Biosciences) and were compensated and analyzed in FCS Express (De Novo Software, v6.05). In data analyses, CD45+ gates were placed individually for each tissue type and experimental group so that 0.3% of the isotype control stained cells were allowed in the gate. Gate placement was constant across the different tissues measured. Isotype control values were subtracted from CD45 antibody-specific stained values on a % basis. FCS Express built-in statistical tokens were employed in a built-in spreadsheet to tabulate outcomes for each tissue and experimental group and in each experiment. Data in built-in spreadsheets were then exported, compiled, and analyzed statistically.
Magnetic Bead Cell Sorting
Cell suspensions were generated identically to that done for flow cytometry and then subjected to T cell (CD4+) magnetic bead sorting as per the manufacturer’s recommendations (Stemcell). Sorted isolates were subjected to flow cytometry as described above.
Antisperm Antibody (ASA) Detections
To detect ASAs bound to sperm, flow cytometry was employed. Immediately after the enzymatic step and cell suspension straining in the flow cytometry protocol, samples were centrifuged at 300 g for 5 min. Epididymal samples consistently produced a cloudy supernatant that was rich in sperm, as visualized in a hemocytometer. Sperm in this supernatant were recovered by additional centrifugation at 600 g, and subjected to the flow cytometry staining procedure described above. Cell viability dye was not employed. For any given sperm sample, cells were either not incubated with staining antibody or incubated with Alexa Fluor 488 anti-mouse IgG or Alexa Fluor 594 anti-mouse IgG (Invitrogen). To detect ASAs in sera, an immunoblot-based assay was conducted. Sperm were isolated from cauda epididymis of non-transgenic C57B6 males by the swim out method in Whittens-HEPES medium and were solubilized in Celis buffer as described previously (). Approximately 200 µg of total sperm protein was resolved on single-lane IPG gels (SDS-PAGE, 10%), which were blotted onto nitrocellulose membranes. Membranes were washed and blocked with 5% non-fat dry milk powder in TBS containing 0.05% Tween-20 (TBST) for 1 h, and then mounted on a Mini-PROTEAN II Multiscreen Apparatus (Bio-Rad). Each serum sample tested was diluted at 1:100 in TBST, and this preparation was applied to a dedicated well in the apparatus for incubation at 4°C overnight. Serum preparations were removed from each well, which were washed with TBST and then replenished with HRP-conjugated anti-mouse IgG at 1:5,000 in TBST. Following incubation for 1 h at room temperature, membranes were unmounted, washed, incubated with Supersignal West Pico HRP substrate (Pierce, IL, USA), and imaged.
Gene Microarray Analysis
RNA was isolated using TRIZOL (Thermo Fisher Scientific) and further purified with the RNeasy PowerClean Pro CleanUp kit (Qiagen). RNA integrity analysis (Bioanalyzer 2100, Agilent) resulted in RIN ≥ 9.0, and RNA concentrations were determined with Nanodrop (Thermo Fisher Scientific). Amplified and biotinylated sense-stranded DNA targets were generated from each of 12 unique RNA samples derived from Cre− and Tgfbr2ΔDC epididymides and testes (n = 3 in each experimental group) using the GeneChip WT PLUS Reagent kit (Affymetrix), and subsequently hybridized to GeneChip Mouse Gene 2.0 ST arrays (Affymetrix). Microarray data analyses were performed using GeneSpring (Agilent, v. 14.9). Data were processed using the RMA16 summarization algorithm and normalized against the mean of control (Cre−) samples for visualization. Statistical analysis was performed using built-in tools, including moderated t-test (p ≤ 0.05) with Westfall–Young multiple testing correction. Gene ontology functional annotation analyses were performed with either GeneSpring or the online tool made available by Database for Annotation, Visualization, and Integrated Discovery (v6.8, National Cancer Institute at Frederick) (, ). Ingenuity Pathway Analysis (IPA) () (Qiagen) was conducted to identify and compare overrepresented pathways affected in Tgfbr2ΔDC epididymides and testes. Additional analyses outcomes, including raw and normalized expression values, can be viewed at the National Center for Biotechnology Information Gene Expression Omnibus microarray depository website (GEO accession no. GSE118262).
Statistical Analyses, Figure Preparation, and Data Availability Statement
Flow cytometry plots were made with FCS Express, while numerical data were compiled in Excel (Microsoft), which was used to calculate means, SEM, and paired t-tests. Bar graphs with SEM were generated in SigmaPlot (Systat Software, v. 6.0) and figures were made in CorelDRAW 2017 (Corel Corporation, v19.1). The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Results
TGFβ-Signaling Loss in DCs Leads to Severe Epididymal Leukocytosis
Dendritic cells populate the epididymal peritubular and interstitial spaces and, in the initial segment of the epididymis, DCs are also located within the epithelial layer (, ). The overall goal of this study was to test whether DCs have a role in maintaining immunotolerance to sperm and, specifically, whether TGFβ signaling in DCs is a factor required for sperm immunotolerance. To begin assessing this, we hypothesized that adult male mice carrying significant TGFβ signaling reduction in DCs specifically (Tgfbr2ΔDC males) would exhibit epididymal leukocytosis. Histopathological analyses were derived from Tgfbr2ΔDC epididymis and testis, along with the respective littermate control (Cre−) tissues. Epididymal leukocytosis was detected in all Tgfbr2ΔDC samples analyzed (Figure 1). Importantly, leukocyte infiltrations were present also in the luminal spaces, where leukocytes were in direct contact with sperm (Figures 1A,C,D). Frequently affected epididymal portions were the corpus and cauda epididymis (Figures 1C,D,F); however, the initial segment and caput of the Tgfbr2ΔDC epididymis also exhibited luminal leukocytosis and granuloma with duct obstruction (Figure 1E). Epididymal granulomas were detected in 4 of 12 Tgfbr2ΔDC males analyzed. The Tgfbr2ΔDC testes did not present signs of leukocytosis, even in those males with epididymal granulomas (Figures 1G,H). However, in one of these males, the testis exhibited histopathology that appeared to derive from excurrent duct obstruction (Figures 1I–K). These histopathological outcomes suggest that DCs support immunotolerance in the epididymis and that TGFβ signaling in these cells is required for the maintenance of epididymal immunotolerance. It remains unknown whether DCs regulate tolerance in an active tolerogenic manner that is TGFβ signaling dependent. Alternatively, TGFβ signaling in DCs may maintain epididymal immunotolerance by keeping DCs in a passive state, possibly in an immature or non-functional (no antigen presentation) state.
Figure 1
Adult Males Lacking TGFβ Signaling in DCs and Mature Lymphocytes Do Not Develop Epididymal Leukocytosis
Mice carrying germline deletion of recombination activating gene 2 (Rag2−/−) do not acquire mature T and B cells (), and this murine model is extensively employed in testing the participation of lymphocytes in various inflammatory contexts. We generated Tgfbr2ΔDC males in the Rag2−/− background (Tgfbr2ΔDCRag2−/−) and examined their epididymis and testis by histology. Leukocytosis was not detected in any of the adult (8–10 weeks old) Tgfbr2ΔDCRag2−/− epididymides (Figure 2) or testes (data not shown). These outcomes suggest that the immune response that impacts the epididymis with severe leukocytosis (when males carry disruption of TGFβ signaling in DCs) requires the participation and chemotaxis of T and/or B cells to this tissue.
Figure 2
Flow Cytometry Detects Leukocytosis in Tgfbr2ΔDC Epididymis but Not Testis; Tregs Are Increased in Both
To test for leukocytosis in Tgfbr2ΔDC male tissues at the molecular level, flow cytometric analyses were conducted to quantify CD45+ cells (leukocytes) in control (Cre−) and Tgfbr2ΔDC epididymis and testis. Kidneys from the same mice, serving as a reference tissue of similar embryological origin that is free of sperm, were also analyzed. In addition, DCs are known to regulate peripheral tolerance by inducing differentiation of Tregs () and Tgfbr2ΔDC mice are known to exhibit altered Treg phenotype (). Expression of forkhead box P3 (FoxP3) is essential for Treg development and function (, ) and is recognized as an unambiguous Treg marker (). To facilitate Treg analyses in Tgfbr2ΔDC mice, a GFP knock-in allele (FoxP3-GFP) was bred in, and both the controls (Cre−) and Tgfbr2ΔDC mice tested expressed GFP downstream from Treg specific FoxP3 expression. Thus, in these experiments, leukocytes were identified and quantified by immunolabeling with monoclonal anti-mouse CD45 directly conjugated to PE-Cy5, while Tregs were identified and quantified via detection of FoxP3-induced GFP. Spleen cell suspensions were also tested to unequivocally identify GFP+ cells (Tregs) exhibiting morphology (forward and side scatters) consistent with those of T cells and for use in the generation of flow cytometry compensation matrices (GFP and live/dead signals, data not shown). Outcomes indicated that the Tgfbr2ΔDC epididymis contains a significantly more abundant CD45+ population, whereas the Tgfbr2ΔDC kidney exhibits a suggestive increase in CD45+ cells that did not reach statistical significance (Figures 3A,B). In the Tgfbr2ΔDC testis, the quantity of CD45+ cells was unchanged or only slightly decreased (Figure 3B). Tregs were significantly increased in both the Tgfbr2ΔDC epididymis and testis (Figure 3C). Interestingly, despite harboring the largest CD45+ population on average, the testis presented the smallest Treg population among the Cre− tissues tested. These flow cytometry outcomes quantitatively frame what the histopathology outcomes had suggested. The adult Tgfbr2ΔDC epididymis contains the most leukocytes, whereas the Tgfbr2ΔDC testis occupies the opposite end of the spectrum with no changes (or a non-significant decrease) in the CD45+ population. Importantly, these results suggest that the Tgfbr2ΔDC epididymis and testis contain significant expansions in their Treg compartments. In these initial experiments, the numbers of Tregs detected in control testis samples were very low. This was initially assumed to be due, at least in part, to the fact that the total number of events recorded per sample was 105. This and the known role of Tregs in immunotolerance prompted a dedicated set of experiments to quantify Tregs in control and Tgfbr2ΔDC male tissues.
Figure 3
The Tgfbr2ΔDC Epididymis and Testis Exhibit Treg Increases
Regulatory T cells were shown to be required for suppression of orchitis in a murine model of vasectomy pathology () and our initial flow cytometry results (Figure 3) showed the Tgfbr2ΔDC testis does not exhibit leukocytosis, but a significant increase in Tregs. Furthermore, the phenotype of Tgfbr2ΔDC Tregs from spleen and mesenteric lymph nodes is altered in regard to expression of interleukin-2 (IL-2) receptor α-chain (CD25) and other parameters (). Therefore, we conducted an additional set of experiments to identify Treg phenotypic differences. Cell suspensions derived from all epididymal and testicular tissues, along with 50 million splenocytes from each of 3 control and 3 Tgfbr2ΔDC males were sorted magnetically based on CD4 expression. CD4+ cell isolates were then subjected to flow cytometry detecting FoxP3-induced GFP fluorescence and CD25. In flow cytometry, forward scatter-height data were also acquired, thus allowing for gating and analyses of singlet cells (Figure 4A, gate R1). The control (Cre−) epididymis and testis contained low Treg numbers (Figure 4A, gate R3 and Figure 4B). However, Tregs were markedly increased in the Tgfbr2ΔDC epididymis and testis (Figures 4A,B). FoxP3 expression in male tissue Tregs was significantly greater than in splenic Tregs, and significantly greater in Tgfbr2ΔDC testicular Tregs than in their Cre− counterparts (Figure 4C). The proportion of CD25+ Tregs was significantly reduced in all Tgfbr2ΔDC tissues tested, compared with Cre− controls (Figure 4D). Together, these results suggest that the epididymis and testis contain, at steady state, relatively few Tregs but that these Treg compartments expand by several folds in a pro-inflammatory scenario such as that of the Tgfbr2ΔDC male tract. It remains to be tested whether these Treg populations exhibit suppressor function and whether Treg expansions regulate (suppress) inflammatory leukocytosis in the Tgfbr2ΔDC testis and epididymis.
Figure 4
Adult Tgfbr2ΔDC Males Exhibit an Immune Response That Targets Sperm Specifically
Figure 1 shows that leukocytes infiltrate into the Tgfbr2ΔDC epididymal lumen and, although this suggests that the Tgfbr2ΔDC epididymal immune response is sperm targeted, more definitive evidence of a sperm-specific immune response was not available. To address this, we tested for ASAs both bound to sperm and free in sera. ASAs bound to sperm were quantified by incubating sperm-rich cells suspensions in the presence or absence of a fluorophore-conjugated anti-mouse immunoglobulin G (IgG) antibody and subsequent flow cytometry. Results from this approach reveal that sperm from Tgfbr2ΔDC mice exhibit a bound ASA signal that is, on average, 60% greater than that presented by sperm from Cre− littermates (Figures 5A,B). In an immunoblot-based assay, we tested for presence or absence of free ASAs in sera from adults and assessed the specificity of the signals by also testing sera from virgin females. Sera from Tgfbr2ΔDC males generated abundant ASA signals (Figure 5C). These results demonstrate unequivocally that Tgfbr2ΔDC males generate an immune response against sperm, supporting the overarching hypothesis of this study, i.e., that TGFβ signaling in DCs is required for immunotolerance to sperm. Outcomes presented in Figures 1–5 suggest that epididymal DCs, once deprived of TGFβ signaling, will initiate a sperm-specific immune response that translates onto epididymal inflammatory leukocytosis and ASAs. Results in Figure 4 suggest the epididymal and testicular Treg expansions occur as an attempt to maintain immunotolerance to sperm.
Figure 5
Distinct Epididymal and Testicular Transcriptomes in Tgfbr2ΔDC Males
Results acquired to this point indicated sharp differences between the Tgfbr2ΔDC epididymis and testis at the histopathological and immunological levels. To test for whole-organ transcriptional differences, we derived microarray-based gene expression analysis from Cre− and Cre+ tissues (littermates). As depicted in Figure 6, consistent with the inflammatory response detected in the epididymis, significant changes in gene expression were observed in this tissue: 419 transcript cluster IDs (TCIDs) were differentially regulated under stringent statistical parameters (Figure 6A). In the testis, 246 TCIDs were differentially expressed, and this expression was within a narrower range than that of the epididymis, as can be noted also in the scales for the fold-change color diagrams (Figure 6A). Figure 6B represents these transcriptional differences further by indicating the number and distribution of over- and under-expressed genes along the fold-change ranges of each tissue type. Importantly, there was a negligible overlap between the differentially regulated epididymal and testicular genes (only four TCIDs in common, Figure 6C), providing evidence of very different transcriptional responses to the loss of DC-mediated immunotolerance in those two tissues. IPAs were conducted using the epididymal (419 TCIDs) and testicular (246 TCIDs) sets of regulated genes. Two conclusions are substantiated by the outcomes of IPA analyses. In the epididymis, consistent with the observed leukocytosis, the genes upregulated were associated with inflammatory response pathways such as B cell development, antigen processing and presentation, DC maturation, both Th1 and Th2 cell activation, and others (Figure 7). Two of the most statistically significant biofunction categories identified by IPA were response of antigen-presenting cells and immune response of leukocytes, which were assessed further by network analysis (Figure 8). In the testis, intriguingly, genes and pathways potentially involved with inflammatory response (IL-2, GM-CSF, IL-15, IL-3, JAK/STAT, IL-17, IL-9, and IL-6) were predominantly downregulated (Figure 9). Furthermore, the testis displayed upregulation of genes and pathways involved in metabolism, such as folate transformation, methionine salvage, ketogenesis, and ketolysis (Figure 9). As discussed subsequently, this outcome may constitute the first evidence for a testicular metabolic-based mechanism for maintenance of immunotolerance.
Figure 6
Figure 7
Figure 8
Figure 9
Discussion
Results reported in this study reveal that loss of TGFβ signaling in DCs adversely impacts male reproductive tract health by inducing severe epididymal pathology that is characterized by leukocytosis with granulomas, generation of ASAs and upregulation of pro-inflammatory pathways. Importantly, these data suggest that TGFβ signaling in DCs is a factor required for immunotolerance to sperm in the epididymis and that testicular immunosuppressive factors cannot maintain tolerance in the epididymis when TGFβ signaling in DCs is disrupted.
Although it is possible that TGFβ signaling may simply keep epididymal DCs at an immature and non-functional state, data now available suggest otherwise. Greater than 88% of all CD11c+ cells in C57B6 wild-type epididymis express MHCII, and ~37% of these cells express the activation markers CD80 or CD86 (), suggesting that nearly all epididymal DCs are enabled with antigen presentation capacity and that one-third of this population is activated. As we showed here, abrogation of TGFβ signaling led to epididymal leukocytosis that requires T and/or B cells (Figures 1 and 2). Therefore, the available data suggest that TGFβ signaling induces tolerogenic activity in DCs of the epididymis, an organ that contains, as known to date, the largest DC population of the male tract.
Our results showed that control mice exhibit low Treg numbers in epididymis and testis while the respective Tgfbr2ΔDC organs presented increased Treg numbers and significantly greater FoxP3 expression in Tregs. Moreover, the Tgfbr2ΔDC testes did not exhibit detectable leukocytosis, despite severe leukocytosis and/or granulomas in epididymides. Both the origin and the functional status of Tregs in Tgfbr2ΔDC epididymis and testis remain unknown. Testicular M2 macrophages of the rat are able to induce Treg differentiation in vitro (). Thus, it is possible that M2 macrophages account for at least a portion of the detected Treg increases in the Tgfbr2ΔDC testis. Testicular DCs can actively promote antisperm immunity as shown with the rat experimental orchitis model (), and DCs in the Tgfbr2ΔDC testis are expected to be pro-inflammatory. Despite this, the Tgfbr2ΔDC testis exhibited no leukocytosis while showing downregulation of genes and pathways associated with inflammation, which strongly suggests that there are robust immunosuppressive mechanisms actively functioning in this organ to maintain immunotolerance. As shown with the mouse vasectomy model, Tregs can maintain the testis free of inflammation while vasectomy-induced epididymitis is present (). Therefore, Tregs can contribute to immunotolerance in the Tgfbr2ΔDC testis. Additional testicular immunosuppressive factors may be contributing to the Tgfbr2ΔDC testicular phenotype as well. M2 macrophages themselves are immunosuppressive and abundant in the testis (, ). Sertoli cells can secrete factors that have direct immunosuppressive activity (–). Our transcriptional analyses suggest an additional and novel mechanistic element in that the testis exhibited altered metabolism when antisperm immunity is present. Specifically, IPA analysis showed that the only upregulated pathways were metabolic. Upregulation of ketogenesis and ketolysis suggests that the Tgfbr2ΔDC testis may have switched to using fat as fuel instead of carbohydrates. This switch, as proposed by others, is exactly what allows “a cell” to downregulate MHC expression and co-stimulatory molecules and therefore become less visible to the immune system (). Ultimately, additional investigation is needed to address this possibility and to define the origin and function of Tgfbr2ΔDC testicular and epididymal Tregs and other immunosuppressive factors potentially functioning in the Tgfbr2ΔDC testis.
The results reported in this study enhance our understanding of male tract immunotolerance and are potentially significant for human clinical research. ASAs and leukocytospermia are prevalent clinical signs detected in infertile men, and ASAs are demonstrated causal factors of human male infertility (, ). Results reported here suggest that the primary etiology of both these pathologies can be totally independent of infection, prior male duct obstruction, vasectomy, or trauma; and can originate at—and be restricted to—the epididymis. Finally, the unique immunosuppressive capacity of the male tract is been recognized as a strong candidate justification to how Zika, HIV, and Ebola viruses escape complete clearance and remain transmissible in the epididymis (Ebola) or testis (, ).
The outcomes reported here appear to also highlight the importance of peripheral—and in the case of the epididymis and sperm antigens, DC-mediated—mechanisms of tolerance for immunotolerance to sperm, male reproductive tract integrity, and function. Disruption of central tolerance by global ablation of the autoimmune regulator in mice does not induce testicular lymphocytic infiltrations, and ASAs or epididymal pathology have not been demonstrated (–).
Ultimately, data reported here suggest that TGFβ signaling in DCs is required for immunotolerance to sperm in the epididymis, as mice lacking TGFβ signaling in DCs are shown to develop severe epididymal inflammatory pathology and ASAs.
Statements
Ethics statement
All mice used in the reported study were generated and utilized under the guidelines of an animal protocol approved by the Kansas State University Institutional Animal Care and Use Committee (IACUC; to Dr. Pierucci-Alves), and by the University of Arizona IACUC (to Dr. Kiela).
Author contributions
FP-A conceived study. FP-A and PK planned and executed experimental work, data analyses, and wrote the manuscript. MM-K, SF, and BS contributed to experimental work and/or resources needed and/or data analyses and/or manuscript writing.
Funding
This work was supported by NIH/NIGMS P20 GM103418 (FP-A, SF, and BS), K-State Johnson Cancer Research Center (Innovative Research Award to FP-A), K-State College of Veterinary Medicine (Success-FYI Award to FP-A) and NIH 5R01 DK109711 (to PK). This manuscript represents contribution number 18-608-J from the Kansas Agricultural Experiment Station.
Conflict of interest
The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
RobaireBHintonBT. Chapter 17 – The epididymis. Knobil and Neill’s Physiology of Reproduction. San Diego: Academic Press (2015). p. 691–771.
2
VojtiskovaM. H-2d antigens on mouse spermatozoa. Nature (1969) 222(5200):1293–4.10.1038/2221293a0
3
MukherjeeDCAgrawalAKManjunathRMukherjeeAB. Suppression of epididymal sperm antigenicity in the rabbit by uteroglobin and transglutaminase in vitro. Science (1983) 219(4587):989–91.10.1126/science.6130601
4
FijakMMeinhardtA. The testis in immune privilege. Immunol Rev (2006) 213:66–81.10.1111/j.1600-065X.2006.00438.x
5
KaurGMitalPDufourJM. Testis immune privilege – assumptions versus facts. Anim Reprod (2013) 10(1):3–15.
6
MitalPHintonBTDufourJM. The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod (2011) 84(5):851–8.10.1095/biolreprod.110.087452
7
HedgerMP. Immunophysiology and pathology of inflammation in the testis and epididymis. J Androl (2011) 32(6):625–40.10.2164/jandrol.111.012989
8
Da SilvaNCortez-RetamozoVReineckerHCWildgruberMHillEBrownDet alA dense network of dendritic cells populates the murine epididymis. Reproduction (2011) 141(5):653–63.10.1530/REP-10-0493
9
BanchereauJSteinmanRM. Dendritic cells and the control of immunity. Nature (1998) 392(6673):245–52.10.1038/32588
10
WranaJLAttisanoLCarcamoJZentellaADoodyJLaihoMet alTGF beta signals through a heteromeric protein kinase receptor complex. Cell (1992) 71(6):1003–14.10.1016/0092-8674(92)90395-S
11
LiuFHataABakerJCDoodyJCarcamoJHarlandRMet alA human Mad protein acting as a BMP-regulated transcriptional activator. Nature (1996) 381(6583):620–3.10.1038/381620a0
12
YueJMulderKM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol Biol (2000) 142:125–31.10.1385/1-59259-053-5:125
13
ShiYMassagueJ. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 113(6):685–700.10.1016/S0092-8674(03)00432-X
14
AttisanoLWranaJL. Signal transduction by the TGF-beta superfamily. Science (2002) 296(5573):1646–7.10.1126/science.1071809
15
ThieryJP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 2(6):442–54.10.1038/nrc822
16
ThieryJPAcloqueHHuangRYNietoMA. Epithelial-mesenchymal transitions in development and disease. Cell (2009) 139(5):871–90.10.1016/j.cell.2009.11.007
17
ShullMMOrmsbyIKierABPawlowskiSDieboldRJYinMet alTargeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 359(6397):693–9.10.1038/359693a0
18
DieboldRJEisMJYinMOrmsbyIBoivinGPDarrowBJet alEarly-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A (1995) 92(26):12215–9.10.1073/pnas.92.26.12215
19
GorelikLFlavellRA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity (2000) 12(2):171–81.10.1016/S1074-7613(00)80170-3
20
PolitchJATuckerLBowmanFPAndersonDJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod (2007) 22(11):2928–35.10.1093/humrep/dem281
21
DesaiKVFlandersKCKondaiahP. Expression of transforming growth factor-beta isoforms in the rat male accessory sex organs and epididymis. Cell Tissue Res (1998) 294(2):271–7.10.1007/s004410051177
22
BomgardnerDWehrenbergURuneGM. TGF-beta could be involved in paracrine actions in the epididymis of the marmoset monkey (Callithrix jacchus). J Androl (1999) 20(3):375–83.
23
HendersonNACookeGMRobaireB. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition. J Endocrinol (2006) 190(3):779–91.10.1677/joe.1.06862
24
Pierucci-AlvesFYiSSchultzBD. Transforming growth factor beta 1 induces tight junction disruptions and loss of transepithelial resistance across porcine vas deferens epithelial cells. Biol Reprod (2012) 86(2):36.10.1095/biolreprod.111.092262
25
RamalingamRLarmonierCBThurstonRDMidura-KielaMTZhengSGGhishanFKet alDendritic cell-specific disruption of TGF-beta receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J Immunol (2012) 189(8):3878–93.10.4049/jimmunol.1201029
26
WangYKissenpfennigAMingueneauMRichelmeSPerrinPChevrierSet alTh2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J Immunol (2008) 180(3):1565–75.10.4049/jimmunol.180.3.1565
27
YuYRO’KorenEGHottenDFKanMJKopinDNelsonERet alA protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS One (2016) 11(3):e0150606.10.1371/journal.pone.0150606
28
WalshTJSeegerKTTurekPJ. Spermatoceles in adults: when does size matter?Arch Androl (2007) 53(6):345–8.10.1080/01485010701730690
29
ShettyJDiekmanABJayesFCShermanNENaaby-HansenSFlickingerCJet alDifferential extraction and enrichment of human sperm surface proteins in a proteome: identification of immunocontraceptive candidates. Electrophoresis (2001) 22(14):3053–66.10.1002/1522-2683(200108)22:14<3053::AID-ELPS3053>3.0.CO;2-K
30
Huang daWShermanBTLempickiRA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 4(1):44–57.10.1038/nprot.2008.211
31
Huang daWShermanBTLempickiRA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2009) 37(1):1–13.10.1093/nar/gkn923
32
KramerAGreenJPollardJJrTugendreichS. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics (2014) 30(4):523–30.10.1093/bioinformatics/btt703
33
ShumWWSmithTBCortez-RetamozoVGrigoryevaLSRoyJWHillEet alEpithelial basal cells are distinct from dendritic cells and macrophages in the mouse epididymis. Biol Reprod (2014) 90(5):90.10.1095/biolreprod.113.116681
34
ShinkaiYRathbunGLamKPOltzEMStewartVMendelsohnMet alRAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 68(5):855–67.10.1016/0092-8674(92)90029-C
35
WakkachAFournierNBrunVBreittmayerJPCottrezFGrouxH. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 18(5):605–17.10.1016/S1074-7613(03)00113-4
36
HoriSNomuraTSakaguchiS. Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299(5609):1057–61.10.1126/science.1079490
37
FontenotJDGavinMARudenskyAY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 4(4):330–6.10.1038/ni904
38
FontenotJDRasmussenJPWilliamsLMDooleyJLFarrAGRudenskyAY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity (2005) 22(3):329–41.10.1016/j.immuni.2005.01.016
39
WheelerKTardifSRivalCLuuBBuiEDel RioRet alRegulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy. Proc Natl Acad Sci U S A (2011) 108(18):7511–6.10.1073/pnas.1017615108
40
WangMFijakMHossainHMarkmannMNusingRMLochnitGet alCharacterization of the micro-environment of the testis that shapes the phenotype and function of testicular macrophages. J Immunol (2017) 198(11):4327–40.10.4049/jimmunol.1700162
41
RivalCGuazzoneVAvon WulffenWHacksteinHSchneiderELustigLet alExpression of co-stimulatory molecules, chemokine receptors and proinflammatory cytokines in dendritic cells from normal and chronically inflamed rat testis. Mol Hum Reprod (2007) 13(12):853–61.10.1093/molehr/gam067
42
WinnallWRMuirJAHedgerMP. Rat resident testicular macrophages have an alternatively activated phenotype and constitutively produce interleukin-10 in vitro. J Leukoc Biol (2011) 90(1):133–43.10.1189/jlb.1010557
43
BellgrauDGoldDSelawryHMooreJFranzusoffADukeRC. A role for CD95 ligand in preventing graft rejection. Nature (1995) 377(6550):630–2.10.1038/377630a0
44
SipioneSSimmenKCLordSJMotykaBEwenCShostakIet alIdentification of a novel human granzyme B inhibitor secreted by cultured Sertoli cells. J Immunol (2006) 177(8):5051–8.10.4049/jimmunol.177.8.5051
45
Suarez-PinzonWKorbuttGSPowerRHootonJRajotteRVRabinovitchA. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes (2000) 49(11):1810–8.10.2337/diabetes.49.11.1810
46
NewellMKVillalobos-MenueyESchweitzerSCHarperMECamleyRE. Cellular metabolism as a basis for immune privilege. J Immune Based Ther Vaccines (2006) 4:1.10.1186/1476-8518-4-1
47
NazRK. Modalities for treatment of antisperm antibody mediated infertility: novel perspectives. Am J Reprod Immunol (2004) 51(5):390–7.10.1111/j.1600-0897.2004.00174.x
48
BrackettNLCohenDRIbrahimEAballaTCLynneCM. Neutralization of cytokine activity at the receptor level improves sperm motility in men with spinal cord injuries. J Androl (2007) 28(5):717–21.10.2164/jandrol.106.002022
49
ChakradharS. Puzzling over privilege: how the immune system protects—and fails—the testes. Nat Med (2018) 24(1):2–5.10.1038/nm0118-2
50
ZengXBlancettCDKoistinenKASchellhaseCWBearssJJRadoshitzkySRet alIdentification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol (2017) 2:17113.10.1038/nmicrobiol.2017.113
51
KurodaNMitaniTTakedaNIshimaruNArakakiRHayashiYet alDevelopment of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol (2005) 174(4):1862–70.10.4049/jimmunol.174.4.1862
52
HubertFXKinkelSACrewtherPECannonPZWebsterKELinkMet alAire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J Immunol (2009) 182(6):3902–18.10.4049/jimmunol.0802124
53
KekalainenEPontynenNMeriSArstilaTPJarvaH. Autoimmunity, not a developmental defect, is the cause for subfertility of autoimmune regulator (Aire) deficient mice. Scand J Immunol (2015) 81(5):298–304.10.1111/sji.12280
Summary
Keywords
sperm tolerance, infertility, autoimmunity, transforming growth factor, dendritic cells
Citation
Pierucci-Alves F, Midura-Kiela MT, Fleming SD, Schultz BD and Kiela PR (2018) Transforming Growth Factor Beta Signaling in Dendritic Cells Is Required for Immunotolerance to Sperm in the Epididymis. Front. Immunol. 9:1882. doi: 10.3389/fimmu.2018.01882
Received
17 June 2018
Accepted
30 July 2018
Published
16 August 2018
Volume
9 - 2018
Edited by
Song Guo Zheng, Penn State Milton S. Hershey Medical Center, United States
Reviewed by
Jesus Rivera-Nieves, University of California, San Diego, United States; Muriel Moser, Free University of Brussels, Belgium
Updates
Copyright
© 2018 Pierucci-Alves, Midura-Kiela, Fleming, Schultz and Kiela.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fernando Pierucci-Alves, falves@vet.k-state.edu
Specialty section: This article was submitted to Immunological Tolerance and Regulation, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.